GB202319953D0 - Tablet formulations involving alvelestat - Google Patents
Tablet formulations involving alvelestatInfo
- Publication number
- GB202319953D0 GB202319953D0 GBGB2319953.2A GB202319953A GB202319953D0 GB 202319953 D0 GB202319953 D0 GB 202319953D0 GB 202319953 A GB202319953 A GB 202319953A GB 202319953 D0 GB202319953 D0 GB 202319953D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- alvelestat
- tablet formulations
- formulations involving
- involving
- tablet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- QNQZWEGMKJBHEM-UHFFFAOYSA-N 6-methyl-5-(2-methylpyrazol-3-yl)-n-[(5-methylsulfonylpyridin-2-yl)methyl]-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1N(C=2C=C(C=CC=2)C(F)(F)F)C(C)=C(C=2N(N=CC=2)C)C=C1C(=O)NCC1=CC=C(S(C)(=O)=O)C=N1 QNQZWEGMKJBHEM-UHFFFAOYSA-N 0.000 title 1
- 229950005666 alvelestat Drugs 0.000 title 1
- 239000007916 tablet composition Substances 0.000 title 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2319953.2A GB202319953D0 (en) | 2023-12-22 | 2023-12-22 | Tablet formulations involving alvelestat |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2319953.2A GB202319953D0 (en) | 2023-12-22 | 2023-12-22 | Tablet formulations involving alvelestat |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB202319953D0 true GB202319953D0 (en) | 2024-02-07 |
Family
ID=89767956
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB2319953.2A Pending GB202319953D0 (en) | 2023-12-22 | 2023-12-22 | Tablet formulations involving alvelestat |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB202319953D0 (en) |
-
2023
- 2023-12-22 GB GBGB2319953.2A patent/GB202319953D0/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL285674A (en) | Pharmaceutical formulations | |
| EP4175676A4 (en) | Mucopenetrating formulations | |
| EP4188329A4 (en) | Pharmaceutical formulations comprising tadalafil | |
| GB202005282D0 (en) | Pharmaceutical Formulations | |
| GB202319953D0 (en) | Tablet formulations involving alvelestat | |
| GB202018889D0 (en) | Formulations | |
| GB202009684D0 (en) | Formulations | |
| GB202307626D0 (en) | Pharmaceutical formulations | |
| ZA202212663B (en) | Pharmaceutical formulations | |
| IL308250A (en) | Pharmaceutical formulations | |
| GB202112820D0 (en) | Pharmaceutical formulations | |
| GB202003108D0 (en) | Pharmaceutical formulations | |
| GB202315863D0 (en) | Formulations | |
| GB202307059D0 (en) | Formulations | |
| GB202216961D0 (en) | 5-meo-mt formulations | |
| GB202001439D0 (en) | Drug formulations | |
| EP4232091A4 (en) | Lymph-targeting formulations | |
| GB202115121D0 (en) | Formulations | |
| GB202115127D0 (en) | Formulations | |
| EP4188088A4 (en) | Formulations | |
| GB202103762D0 (en) | Formulations | |
| GB202103780D0 (en) | Formulations | |
| GB202103785D0 (en) | Formulations | |
| IL314206A (en) | Pharmaceutical formulation | |
| GB202216467D0 (en) | Pharmaceutical formulation |